Searchable abstracts of presentations at key conferences in endocrinology

ea0075d23 | Diabetes | EYES2021

2020 Zagreb earthquake and type 1 diabetes management - A pilot study

Zrilic Vrkljan Anamarija , Andric Jelena , Marusic Srecko , Pandzic Jaksic Vlatka

Background: In March 2020, at the beginning of the first COVID-19 lockdown, Zagreb (Croatia) was hit by a strong earthquake aftermore than 100 years.Restrictive epidemiological measures affected people’s lifestyles, and the earthquakewas an additional traumatic event.Objectives: Determine whether the earthquakes and the lockdown affected glycaemic control in type 1 diabetes patients using flash glucose monitoring (FGM).Metho...

ea0099ep973 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Alopecia universalis and epilepsy in a patient with type 1 diabetes

Andric Jelena , Zrilic Vrkljan Anamarija , Pandzic Jaksic Vlatka

Background: Alopecia areata is a common non-endocrine manifestation in autoimmune polyendocrine syndromes (APS). Alopecia universalis is its most severe form with total loss of scalp and body hair. Several attempts at classifications for multiple combinations of autoimmune disorders in APS were proposed. Type 1 diabetes is associated with epilepsy due to glycemic extremes and microvascular damage, but a shared etiology mediated by anti-glutamic acid decarboxylase antibodies (a...

ea0099ep1037 | Pituitary and Neuroendocrinology | ECE2024

Chronic granulomatous mastitis in a patient with microprolactinoma

Hrabar Mirna , Zrilic Vrkljan Anamarija , Pandzic Jaksic Vlatka

Treatment of patients with a microprolactinoma is considered when hypogonadism is present in the form of menstrual cycle dysfunction or infertility. The presence of galactorrhea alone does not require treatment unless it is bothersome to the patient. The exact etiology of granulomatous mastitis is still unclear. Hyperprolactinemia has been identified as a possible factor in the occurrence and development of granulomatous mastitis. A 42-year-old female patient was referred to o...

ea0090p532 | Thyroid | ECE2023

Transition from hypothyroidism to hyperthyroidism following R-CHOP treatment in mantle cell lymphoma patient

Zrilic Vrkljan Anamarija , Andric Jelena , Hrabar Mirna , Šamle Ivona , Marusic Srecko , Pandzic Jaksic Vlatka

The most common cause of primary hypothyroidism is Hashimoto’s disease, while the most common cause of hyperthyroidism is Graves’ disease; both conditions are autoimmune diseases. In clinical practice, the switch from hypothyroidism to hyperthyroidism is a rare phenomenon. So far, the etiology and mechanisms of conversion have not been determined. We present a case where we believe the monoclonal antibody rituximab was the primary cause of transition. A 58-year-old m...

ea0099ep432 | Calcium and Bone | ECE2024

Hyperparathyroidism in patients with acute fragility fractures

Zrilic Vrkljan Anamarija , Hrabar Mirna , Andric Jelena , Jaksic Jelena , Pandzic Jaksic Vlatka

Background: An acute fragility fracture is considered a ’bone attack,’ necessitating prompt treatment of osteoporosis. Standard clinical practice involves assessing the patient’s clinical status, comorbidities, and secondary causes of osteoporosis, influencing the choice between osteoanabolic or antiresorptive therapy. Normocalcemic hyperparathyroidism is common among fragility fracture patients. While it is commonly associated with vitamin D deficiency and chro...